ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)

NCT01218971 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

332

Enrollment

INDUSTRY

Sponsor class

Conditions

Alcohol Dependence

Interventions

DRUG: Medisorb naltrexone 190 mg
DRUG: Medisorb naltrexone 380 mg

Sponsor

Alkermes, Inc.